Followers | 211 |
Posts | 20573 |
Boards Moderated | 4 |
Alias Born | 01/09/2019 |
Friday, July 19, 2024 2:26:42 PM
Everything I say is my educated opinion and is NOT investment advice
Recent PSNL News
- Personalis to Announce Second Quarter 2024 Financial Results • Business Wire • 07/24/2024 08:01:00 PM
- Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing • GlobeNewswire Inc. • 07/11/2024 01:00:00 PM
- Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference • Business Wire • 06/18/2024 08:01:00 PM
- Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call • Business Wire • 06/13/2024 12:00:00 PM
- ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring • Business Wire • 06/04/2024 08:05:00 PM
- Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus • Business Wire • 05/31/2024 01:05:00 PM
- Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024 • Business Wire • 05/22/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 01:14:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 01:11:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:12:17 PM
- Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/17/2024 08:05:00 PM
- Personalis Reports First Quarter 2024 Financial Results • Business Wire • 05/08/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:00:17 PM
- Personalis to Announce First Quarter 2024 Financial Results • Business Wire • 04/24/2024 08:01:00 PM
- Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 03/28/2024 08:01:00 PM
- Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting • Business Wire • 03/28/2024 01:00:00 PM
- Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring • Business Wire • 03/26/2024 01:00:00 PM
- Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/19/2024 08:43:00 PM
- Personalis Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/28/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:00:11 PM
- Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/14/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:30:33 PM
- Personalis to Participate at Upcoming Investor Conferences • Business Wire • 01/31/2024 09:01:00 PM
- Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology • Business Wire • 01/30/2024 02:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/29/2024 09:00:59 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM